The most defined therapeutic molecular classification of breast cancer is based on the status of oestrogen receptors (ER), progesterone receptors (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 [4–6]. Here, MKI67 is linked to breast carcinoma.